APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Enzalutamide Tablets Industry Growth and Trends Forecast to 2032

28 December 202572 pages

Choose your research edition.

Industry ResearchEnzalutamide Tablets Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Tablets Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Enzalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Enzalutamide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Enzalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Enzalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enzalutamide Tablets include Astellas/Pfizer and AURISCO among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Enzalutamide Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enzalutamide Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enzalutamide Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enzalutamide Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Enzalutamide Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enzalutamide Tablets Market by Company

Astellas/Pfizer

AURISCO

Enzalutamide Tablets Segment by Type

40mg

80mg

Enzalutamide Tablets Segment by Application

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Castration- Resistant Prostate Cancer (NM-CRPC)

Enzalutamide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enzalutamide Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Enzalutamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 40mg Table 2. Major Company of 80mg Table 3. Global Enzalutamide Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Enzalutamide Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Enzalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Enzalutamide Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Enzalutamide Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Enzalutamide Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Enzalutamide Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Enzalutamide Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Enzalutamide Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Enzalutamide Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Enzalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Enzalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Enzalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Enzalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Enzalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Enzalutamide Tablets Industry Trends Table 25. Enzalutamide Tablets Industry Drivers Table 26. Enzalutamide Tablets Industry Opportunities and Challenges Table 27. Enzalutamide Tablets Industry Restraints Table 28. Global Enzalutamide Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Enzalutamide Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Enzalutamide Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Enzalutamide Tablets Sales Share by Company (2021-2026) Table 32. Global Enzalutamide Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Enzalutamide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Enzalutamide Tablets Major Company Production Sites and Headquarters Table 35. Global Enzalutamide Tablets Company, Product Type & Application Table 36. Global Enzalutamide Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Enzalutamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Enzalutamide Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Enzalutamide Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Enzalutamide Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Enzalutamide Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Enzalutamide Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Enzalutamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Enzalutamide Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Enzalutamide Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Enzalutamide Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Enzalutamide Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Enzalutamide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Enzalutamide Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Enzalutamide Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Enzalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Enzalutamide Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Enzalutamide Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Enzalutamide Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Enzalutamide Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Enzalutamide Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Enzalutamide Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Enzalutamide Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Enzalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Enzalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Enzalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Enzalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Enzalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Astellas/Pfizer Company Information Table 72. Astellas/Pfizer Business Overview Table 73. Astellas/Pfizer Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Astellas/Pfizer Enzalutamide Tablets Product Portfolio Table 75. Astellas/Pfizer Recent Development Table 76. AURISCO Company Information Table 77. AURISCO Business Overview Table 78. AURISCO Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AURISCO Enzalutamide Tablets Product Portfolio Table 80. AURISCO Recent Development Table 81. North America Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 83. North America Enzalutamide Tablets Sales Market Share by Country (2021-2026) Table 84. North America Enzalutamide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Enzalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 86. North America Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Enzalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Enzalutamide Tablets Market Share by Country (2021-2026) Table 89. North America Enzalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Enzalutamide Tablets Market Share Forecast by Country (2027-2032) Table 91. Europe Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 93. Europe Enzalutamide Tablets Sales Market Share by Country (2021-2026) Table 94. Europe Enzalutamide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Enzalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Enzalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Enzalutamide Tablets Market Share by Country (2021-2026) Table 99. Europe Enzalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Enzalutamide Tablets Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Enzalutamide Tablets Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Enzalutamide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Enzalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Enzalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Enzalutamide Tablets Market Share by Country (2021-2026) Table 109. Asia-Pacific Enzalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Enzalutamide Tablets Market Share Forecast by Country (2027-2032) Table 111. Latin America Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 113. Latin America Enzalutamide Tablets Sales Market Share by Country (2021-2026) Table 114. Latin America Enzalutamide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Enzalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Enzalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Enzalutamide Tablets Market Share by Country (2021-2026) Table 119. Latin America Enzalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Enzalutamide Tablets Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Enzalutamide Tablets Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Enzalutamide Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Enzalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Enzalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Enzalutamide Tablets Market Share by Country (2021-2026) Table 129. Middle East and Africa Enzalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Enzalutamide Tablets Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Enzalutamide Tablets Distributors List Table 134. Enzalutamide Tablets Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Enzalutamide Tablets Image Figure 2. Global Enzalutamide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzalutamide Tablets Sales (2021-2032) & (K Units) Figure 5. 40mg Image Figure 6. Global 40mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 80mg Image Figure 8. Global 80mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Enzalutamide Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Enzalutamide Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Enzalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Enzalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Enzalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Enzalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Enzalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Enzalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Enzalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Enzalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Enzalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Enzalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Enzalutamide Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Image Figure 24. Global Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Sales YoY Growth (2021-2032) & (K Units) Figure 25. Castration- Resistant Prostate Cancer (NM-CRPC) Image Figure 26. Global Castration- Resistant Prostate Cancer (NM-CRPC) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Enzalutamide Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Enzalutamide Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Enzalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Enzalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Enzalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Enzalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Enzalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Enzalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Enzalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Enzalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Enzalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Enzalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Enzalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Enzalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Enzalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Enzalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Enzalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Enzalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Enzalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Enzalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Enzalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Enzalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Enzalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Enzalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Enzalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Enzalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Enzalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Enzalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Enzalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Enzalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Enzalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Enzalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Enzalutamide Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Enzalutamide Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • Castration- Resistant Prostate Cancer (NM-CRPC)
Companies covered
  • Astellas/Pfizer
  • AURISCO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enzalutamide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Enzalutamide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Enzalutamide Tablets Market by Type
  6. 1.3.1 40mg
  7. 1.3.2 80mg
  8. 1.4 Global Enzalutamide Tablets Market Size by Type
  9. 1.4.1 Global Enzalutamide Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Enzalutamide Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Enzalutamide Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Enzalutamide Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Enzalutamide Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Enzalutamide Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Enzalutamide Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Enzalutamide Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Enzalutamide Tablets Industry Trends
  2. 2.2 Enzalutamide Tablets Industry Drivers
  3. 2.3 Enzalutamide Tablets Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Enzalutamide Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Enzalutamide Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Enzalutamide Tablets Price (2021-2026)
  4. 3.4 Global Enzalutamide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enzalutamide Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Enzalutamide Tablets Company, Product Type & Application
  7. 3.7 Global Enzalutamide Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enzalutamide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enzalutamide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enzalutamide Tablets Tier 1, Tier 2, and Tier 3
4 Enzalutamide Tablets Regional Status and Outlook
  1. 4.1 Global Enzalutamide Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Enzalutamide Tablets Historic Market Size by Region
  3. 4.2.1 Global Enzalutamide Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Enzalutamide Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Enzalutamide Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Enzalutamide Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Enzalutamide Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Enzalutamide Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Enzalutamide Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Enzalutamide Tablets by Application
  1. 5.1 Enzalutamide Tablets Market by Application
  2. 5.1.1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  3. 5.1.2 Castration- Resistant Prostate Cancer (NM-CRPC)
  4. 5.2 Global Enzalutamide Tablets Market Size by Application
  5. 5.2.1 Global Enzalutamide Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Enzalutamide Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Enzalutamide Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Enzalutamide Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Enzalutamide Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Enzalutamide Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Enzalutamide Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Enzalutamide Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Astellas/Pfizer
  2. 6.1.1 Astellas/Pfizer Company Information
  3. 6.1.2 Astellas/Pfizer Business Overview
  4. 6.1.3 Astellas/Pfizer Enzalutamide Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Astellas/Pfizer Enzalutamide Tablets Product Portfolio
  6. 6.1.5 Astellas/Pfizer Recent Developments
  7. 6.2 AURISCO
  8. 6.2.1 AURISCO Company Information
  9. 6.2.2 AURISCO Business Overview
  10. 6.2.3 AURISCO Enzalutamide Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AURISCO Enzalutamide Tablets Product Portfolio
  12. 6.2.5 AURISCO Recent Developments
7 North America by Country
  1. 7.1 North America Enzalutamide Tablets Sales by Country
  2. 7.1.1 North America Enzalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Enzalutamide Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Enzalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Enzalutamide Tablets Market Size by Country
  6. 7.2.1 North America Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Enzalutamide Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Enzalutamide Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Enzalutamide Tablets Sales by Country
  2. 8.1.1 Europe Enzalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Enzalutamide Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Enzalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Enzalutamide Tablets Market Size by Country
  6. 8.2.1 Europe Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Enzalutamide Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Enzalutamide Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Enzalutamide Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Enzalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Enzalutamide Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Enzalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Enzalutamide Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Enzalutamide Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Enzalutamide Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Enzalutamide Tablets Sales by Country
  2. 10.1.1 South America Enzalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Enzalutamide Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Enzalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Enzalutamide Tablets Market Size by Country
  6. 10.2.1 South America Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Enzalutamide Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Enzalutamide Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Enzalutamide Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Enzalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Enzalutamide Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Enzalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Enzalutamide Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Enzalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Enzalutamide Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Enzalutamide Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Enzalutamide Tablets Value Chain Analysis
  2. 12.1.1 Enzalutamide Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Enzalutamide Tablets Production Mode & Process
  7. 12.2 Enzalutamide Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Enzalutamide Tablets Distributors
  10. 12.2.3 Enzalutamide Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst